Articles published by OKYO Pharma LTD
OKYO Pharma to Present at the Biotech Showcase Conference in San Francisco, January 8-10, 2024
January 05, 2024
From OKYO Pharma LTD
Via GlobeNewswire
Tickers
OKYO
OKYO Pharma Announces Closing of $4.0 Million Registered Direct Offering of Ordinary Shares
September 15, 2023
From OKYO Pharma LTD
Via GlobeNewswire
Tickers
OKYO
OKYO Pharma Announces Pricing of $4.0 Million Registered Direct Offering of Ordinary Shares
September 14, 2023
From OKYO Pharma LTD
Via GlobeNewswire
Tickers
OKYO
OKYO Pharma Limited Announces Withdrawal of Public Offering
September 14, 2023
From OKYO Pharma LTD
Via GlobeNewswire
Tickers
OKYO
OKYO Pharma Announces Public Offering of Ordinary Shares
September 13, 2023
From OKYO Pharma LTD
Via GlobeNewswire
Tickers
OKYO
OKYO Pharma Completes Enrollment in Phase 2 Clinical Trial of OK-101 to treat Dry Eye Disease
September 08, 2023
From OKYO Pharma LTD
Via GlobeNewswire
Tickers
OKYO
OKYO Pharma Limited Regains Compliance with Nasdaq Listing Minimum Market Value Rule
August 29, 2023
From OKYO Pharma LTD
Via GlobeNewswire
Tickers
OKYO
OKYO Pharma Limited Reports Annual Results for the Twelve Months Ended March 31, 2023
August 15, 2023
From OKYO Pharma LTD
Via GlobeNewswire
Tickers
OKYO
OKYO Pharma Limited Receives Nasdaq Deficiency Notice
July 28, 2023
From OKYO Pharma LTD
Via GlobeNewswire
Tickers
OKYO
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.